KCM
ADMA icon

Kornitzer Capital Management’s ADMA Biologics ADMA Stock Holding History

Kornitzer Capital Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-356,867
Closed -$6.51M – 507
2025
Q4 		$6.51M Sell
356,867
-3,118
-0.9% -$52.5K 0.14% 171
2025
Q3 		$5.28M Buy
359,985
+312,115
+652% +$5.35M 0.11% 220
2025
Q2 		$872K Hold
47,870
– – 0.02% 407
2025
Q1 		$950K Buy
47,870
+14,870
+45% +$257K 0.02% 374
2024
Q4 		$566K Buy
+33,000
New +$621K 0.01% 423

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Kornitzer Capital Management's ADMA Position: Q1 2026 in Review

Kornitzer Capital Management sold out of ADMA Biologics (ADMA) in Q1 2026, closing a stake of 356,867 shares — an estimated $6.51M sold.

Kornitzer Capital Management first reported a position in ADMA in Q4 2024 and held it in 5 quarters. The position peaked at $6.51M in Q4 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Kornitzer Capital Management reported no remaining ADMA Biologics position as of Q1 2026 after selling out during the quarter.
  • Kornitzer Capital Management sold 356,867 ADMA Biologics shares in Q1 2026, an estimated $6.51M.
  • Kornitzer Capital Management first reported a position in ADMA Biologics in Q4 2024 and held it in 5 quarters.
  • Kornitzer Capital Management's ADMA Biologics position peaked at $6.51M in Q4 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Kornitzer Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.